NCT00002119View on ClinicalTrials.gov

A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

WF10

Trial Locations (1)

77074

Oncol Med Associates, Houston

All Listed Sponsors
lead

Oxo Chemie GmbH

INDUSTRY